Literature DB >> 34038830

Long-term quality of life in treatment-resistant depression after electroconvulsive therapy.

Heidemarie Lex1, Steven W Nevers1, Erica L Jensen1, Yarden Ginsburg2, Daniel F Maixner2, Brian J Mickey3.   

Abstract

BACKGROUND: Electroconvulsive therapy (ECT) is highly effective for treatment-resistant depression (TRD), and previous studies have demonstrated short-term improvements in quality of life (QoL) after ECT.  However, long-term QoL after ECT has not been studied, and the baseline patient characteristics that predict long-term QoL remain unknown.
METHODS: Seventy-nine subjects with unipolar or bipolar TRD were enrolled in this prospective longitudinal observational study. Physical, psychological, social, and environmental QoL domains were measured with the abbreviated World Health Organization Quality of Life scale (WHOQOL-BREF) at baseline and every 6 months for up to 2 years after ECT.  Baseline sociodemographic and clinical features were tested for association with long-term QoL.
RESULTS: Long-term follow-up data were available from 49 participants.  Relative to baseline, average psychological and physical QoL improved during the follow-up period (Hedges' effect size: 0.27-0.83).  About 40-50% of individuals experienced clinically meaningful improvement.  Subjects with better initial antidepressant response with ECT reported better QoL over the subsequent two years.  Long-term QoL improved most among individuals who were married, those without disability status, and those with psychotic features or shorter depressive episodes at baseline. LIMITATIONS: Participants were from a single US academic center and mainly of European ancestry, so findings may not generalize to other settings or ethnicities.  The observational design does not allow causal inferences.
CONCLUSIONS: Long-term psychological and physical QoL outcomes vary widely after ECT. Individuals with the best outcomes are those who respond well to ECT initially, married people, and those with a less chronic course of illness.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Electroconvulsive Therapy; Minimum Clinically Important Difference; Quality of life, long-term (24months) Quality of Life; Treatment-Resistant Depression; predictors for quality of life

Mesh:

Year:  2021        PMID: 34038830      PMCID: PMC8628522          DOI: 10.1016/j.jad.2021.05.012

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   6.533


  27 in total

1.  The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group.

Authors:  S M Skevington; M Lotfy; K A O'Connell
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

2.  Clinimetrics Corner: The Minimal Clinically Important Change Score (MCID): A Necessary Pretense.

Authors:  Chad E Cook
Journal:  J Man Manip Ther       Date:  2008

3.  Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up.

Authors:  W W IsHak; J Mirocha; D James; G Tobia; J Vilhauer; H Fakhry; S Pi; E Hanson; R Nashawati; E D Peselow; R M Cohen
Journal:  Acta Psychiatr Scand       Date:  2014-06-23       Impact factor: 6.392

4.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

Review 5.  The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF).

Authors:  Harold A Sackeim; Scott T Aaronson; Mark T Bunker; Charles R Conway; Mark A Demitrack; Mark S George; Joan Prudic; Michael E Thase; A John Rush
Journal:  J Psychiatr Res       Date:  2019-03-22       Impact factor: 4.791

6.  Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.

Authors:  W Vaughn McCall; Peter B Rosenquist; James Kimball; Roger Haskett; Keith Isenberg; Joan Prudic; Barbara Lasater; Harold A Sackeim
Journal:  J ECT       Date:  2011-06       Impact factor: 3.635

Review 7.  Improvements in Health-Related Quality of Life With Electroconvulsive Therapy: A Meta-analysis.

Authors:  Peter Giacobbe; Uros Rakita; Kirsten Penner-Goeke; Kfir Feffer; Alastair J Flint; Sidney H Kennedy; Jonathan Downar
Journal:  J ECT       Date:  2018-06       Impact factor: 3.635

8.  Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors.

Authors:  Aazaz U Haq; Adam F Sitzmann; Mona L Goldman; Daniel F Maixner; Brian J Mickey
Journal:  J Clin Psychiatry       Date:  2015-10       Impact factor: 4.384

9.  Hundred forty eight more days with depression: the association between marital conflict and depression-free days.

Authors:  Mijung Park; Jürgen Unützer
Journal:  Int J Geriatr Psychiatry       Date:  2014-04-04       Impact factor: 3.485

10.  Satisfactory results of a psychometric analysis and calculation of minimal clinically important differences of the World Health Organization quality of life-BREF questionnaire in an observational cohort study with lung cancer and mesothelioma patients.

Authors:  Mark de Mol; Sabine Visser; Joachim G J V Aerts; Paul Lodder; Jolanda de Vries; Brenda L den Oudsten
Journal:  BMC Cancer       Date:  2018-11-26       Impact factor: 4.430

View more
  1 in total

1.  Distinct predictors of short- versus long-term depression outcomes following electroconvulsive therapy.

Authors:  Brian J Mickey; Yarden Ginsburg; Erica Jensen; Daniel F Maixner
Journal:  J Psychiatr Res       Date:  2021-12-14       Impact factor: 5.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.